Results 311 to 320 of about 178,517 (322)

Kinase inhibitors: the road ahead

Nature Reviews Drug Discovery, 2018
Fleur M Ferguson, Nathanael S Gray
exaly  

Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target

Nature Reviews Drug Discovery, 2020
Lauren Mifflin, Junying Yuan
exaly  

Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes

Nature Reviews Drug Discovery, 2011
Kyle L Kolaja
exaly  

Rho kinase, a promising drug target for neurological disorders

Nature Reviews Drug Discovery, 2005
Nicole Teusch
exaly  

Targeting innate immunity protein kinase signalling in inflammation

Nature Reviews Drug Discovery, 2009
Matthias Gaestel, Michael Kracht
exaly  

Understanding, recognizing, and managing toxicities of targeted anticancer therapies

Ca-A Cancer Journal for Clinicians, 2013
exaly  

Targeting the phosphoinositide 3-kinase pathway in cancer

Nature Reviews Drug Discovery, 2009
Hailing Cheng, Thomas M Roberts, Jean J Zhao   +2 more
exaly  

Factors underlying sensitivity of cancers to small-molecule kinase inhibitors

Nature Reviews Drug Discovery, 2009
Pasi A Jänne
exaly  

AMP-activated protein kinase: the current landscape for drug development

Nature Reviews Drug Discovery, 2019
Gregory R Steinberg, David Carling, Miriam Merad   +2 more
exaly  

Targeting Apoptosis Pathways in Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2005
exaly